logo
The BC Centre for Excellence in HIV/AIDS national Summit raises alarm about rising incidence of HIV in Canada and threats to global progress

The BC Centre for Excellence in HIV/AIDS national Summit raises alarm about rising incidence of HIV in Canada and threats to global progress

Cision Canadaa day ago

Delegates call on Prime Minister to end the Canadian epidemic and lead the worldwide HIV response in light of dramatic US cuts to treatment and care
VANCOUVER, BC, June 6, 2025 /CNW/ - The BC Centre for Excellence in HIV/AIDS (BC-CfE) is hosting a national Summit of medical and HIV experts to raise the alarm about the rising incidence of HIV in Canada, the immense threat that US cuts to HIV programs pose to millions at risk of disease and death globally, and the need for Canadian leadership to help prevent a resurgence in HIV/AIDS.
Despite the groundbreaking work done to implement the BC-CfE's Treatment as Prevention ® (TasP ®) and HIV Pre-Exposure Prophylaxis (PrEP) programs in many jurisdictions, Canada is losing ground to HIV/AIDS across the country. The latest available government statistics for 2023 show a 35% uptick in HIV cases in Canada compared to 2022. Anecdotal discussions between BC-CfE and HIV experts across Canada indicate the situation continues to deteriorate, with HIV incidence statistics expected to be higher yet again in 2024 and in 2025.
Meanwhile, the United States has substantially decreased funding to domestic programs currently supported by the US Centers for Disease Control and Prevention and Medicare, and international programs supported by PEPFAR (the US President's Emergency Plan for AIDS Relief) and USAID. UNAIDS estimates another 6.6 million new HIV infections and 4.2 million AIDS-related deaths between 2025 and 2029 if US government cuts continue.
At the National TasP Summit, Dr. Julio Montaner, BC-CfE Executive Director & Physician-in-Chief, called on Prime Minister Mark Carney to take the reins and redouble efforts to end the Canadian HIV/AIDS epidemic by 2030, fully fund Highly Active Antiretroviral Therapy (HAART) and PrEP within a national pharmacare plan, and meet the UNAIDS 95-95-95 target for HIV testing, treatment and viral suppression. Meeting the UNAIDS targets * would result in a 90% reduction in HIV/AIDS-related deaths and new infections by 2030, ending the HIV/AIDS epidemic as a public health threat.
"The Prime Minister has called for cost-effective, nation-building projects to improve the lives of Canadians and show leadership," said Dr. Montaner. "Redoubling efforts to defeat HIV/AIDS in Canada by 2030 fits the bill. It saves lives, prevents disease progression, improves quality of life and saves money. We have a plan. We need the Prime Minister's help to get it over the finish line."
In addition, Canada must step up to better support the Global Fund to Fight AIDS, Tuberculosis and Malaria, to provide much-needed international leadership in a renewed and reinvigorated fight against HIV/AIDS. Weakening global efforts for HIV prevention, treatment, and support are already having an impact in British Columbia and throughout Canada. Domestically, HIV prevention and treatment strategies have saved countless lives and dramatically improved the lives of people living with and at-risk of HIV. However, many of Canada's new HIV cases relate to domestic and international migration, demonstrating the need for federal unity in Canada's HIV response and better support for the Global Fund.
"HIV does not respect provincial, Canadian or international borders," said Summit co-chair Dr. Val Montessori, BC-CfE Director of Clinical Education. "With new HIV diagnoses rising across Canada, the need is greater than ever to implement proven HIV prevention and treatment strategies. By working together, we can strengthen the national HIV response in Canada and around the world, improve the lives of people living with HIV, and prevent new cases."
*About the UNAIDS 95-95-95 Targets
Based on the Treatment as Prevention strategy developed by the BC-CfE, the United Nations Joint Programme on HIV/AIDS (UNAIDS) set out ambitious targets in 2014 to end the AIDS epidemic globally by 2030. This culminated in the UN 95-95-95 Targets, which established that countries ensure 95% of people living with HIV are diagnosed, 95% of those diagnosed are on treatment, and 95% of those on treatment are virally suppressed, by the year 2025. Meeting the UN Targets would change the trajectory of the epidemic so that we would see a 90% reduction in HIV/AIDS related deaths and new HIV infections by 2030, which would herald the end of the HIV/AIDS epidemic as a public health threat.
About the British Columbia Centre for Excellence in HIV/AIDS
The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada's largest HIV/AIDS research, treatment and education facility – nationally and internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases. The made-in-BC Treatment as Prevention ® strategy (TasP ®) pioneered by BC-CfE, and adopted by UNAIDS since 2011, inspired the ambitious global target for HIV treatment – known as the United Nations' 90-90-90 Target by 2020 and current UN 95-95-95 Target by 2025 – to end AIDS as a pandemic by 2030. The BC-CfE is applying TasP ® to therapeutic areas beyond HIV/AIDS, including viral hepatitis and addiction, to promote Targeted Disease Elimination ® as a means to contribute to healthcare sustainability. The BC-CfE works in close collaboration with key stakeholders, including government, health authorities, health care providers, academics, and the community to decrease the health burden of HIV/AIDS, hepatitis C and addictions across Canada and around the world.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Over 4,400 Riders Embark on Ride to Conquer Cancer, Canada's Largest Athletic Fundraiser, Raising Over $20.61 Million for Life-Saving Research
Over 4,400 Riders Embark on Ride to Conquer Cancer, Canada's Largest Athletic Fundraiser, Raising Over $20.61 Million for Life-Saving Research

Cision Canada

time5 hours ago

  • Cision Canada

Over 4,400 Riders Embark on Ride to Conquer Cancer, Canada's Largest Athletic Fundraiser, Raising Over $20.61 Million for Life-Saving Research

TORONTO, June 7, 2025 /CNW/ - The 18 th annual The Princess Margaret Ride to Conquer Cancer, presented by Johnson & Johnson, commenced this morning with over 4,000 riders departing from Sherway Gardens, Toronto in a group peloton. At the same time, more than 400 riders began their journey from the Niagara-on-the-Lake start line. Both groups will converge at McMaster University in Hamilton for overnight camp later today. This year's Ride sets a record for funds raised with $20.61 million, surpassing the previous record of $20.6 million set in 2024. United in their mission to create a world free from the fear of cancer, all riders are taking on the two-day, 200+ km journey to Niagara-on-the-Lake in support of Princess Margaret Cancer Centre, one of the world's leading cancer research and treatment centres. "Cancer remains one of the greatest global health threats of our time," said Dr. Miyo Yamashita, President and CEO of The Princess Margaret Cancer Foundation. "Yet, through the unwavering dedication of our Ride community— riders, donors, supporters and volunteers, together we are transforming the way cancer is understood, prevented, diagnosed and treated in Canada and around the world." Among the riders was Dana Fox, who knows firsthand the importance of this cause. Diagnosed with cholangiocarcinoma, a rare and aggressive cancer, Dana is currently undergoing treatment at The Princess Margaret but is committed to completing the 200km journey. "You are fueling hope, you are funding discovery, and you are changing lives," Dana rallied to the crowd in his opening ceremony's patient remarks. "This isn't just a fundraiser. This is a movement." Participants have collectively raised an astounding $20.61 million this year, bringing The Ride's all-time fundraising total to more than $320.61 million since its inception in 2008. These funds directly support life-saving cancer research and patient care at Princess Margaret Cancer Centre, one of the world's leading cancer research and treatment centres. As The Ride's 2025 Honourary Chairs, Nicholas and Lia Fidei said, "After witnessing some of the success stories and meeting cancer patients who have overcome cancer, there is no doubt in our minds how much we need to support The Ride and the advancements in cancer research that The Princess Margaret is renowned for." Nicholas, President of Treasure Hill and President of the Nicholas Fidei Foundation, and this year's top individual fundraiser also added, "No other fundraising event that I have participated in has inspired me to greater achievements." All riders are now making their way to Hamilton, where they'll be welcomed by cheering family and friends, enjoy a hot meal at camp ceremonies and spend the night at McMaster University. On Day 2, they'll continue their journey to the finish line at Peller Estates Winery in Niagara-on-the-Lake. For more information, to donate or to register for the 2026 Ride to Conquer Cancer, please visit The Princess Margaret Cancer Foundation is Canada's largest cancer charity. We're dedicated to raising funds for Princess Margaret Cancer Centre, one of the world's leading cancer research and treatment centres, known for its breakthrough discoveries that transform patient outcomes. Together, our work benefits cancer patients everywhere in our mission to create a world free from the fear of cancer. Through philanthropy, fundraising events, and our world-leading lottery program, we're changing how the world understands, prevents, diagnoses, and treats cancer, benefitting patients at The Princess Margaret, throughout Canada, and around the world. SOURCE Princess Margaret Cancer Foundation

Teva birth control pills recalled across Canada over extra placebos
Teva birth control pills recalled across Canada over extra placebos

Toronto Star

time18 hours ago

  • Toronto Star

Teva birth control pills recalled across Canada over extra placebos

Birth control medication is being pulled from Canadian shelves over extra placebo tablets, Health Canada says. The recall concerns Teva Canada's Seasonale tablet with lot numbers 100059661 and 100069150, according to the agency's recall notice. Health Canada is urging patients not to skip doses or stop taking their birth control. But if your package contains white placebo pills in the first or second blister card tray, don't take them, and return the pills to your pharmacy for a replacement. ARTICLE CONTINUES BELOW If you can't get to a pharmacy right away, take the next pink active pill in the proper order, as laid out in the instructions, until you can get a replacement. If you took a white placebo pill instead of an active pink pill from one of the first two trays, or if you are unsure, you should also use another method of non-hormonal contraception and consult with your health care professional.

3 Canadian national team players among the Whitecaps stricken by illness
3 Canadian national team players among the Whitecaps stricken by illness

Toronto Star

time19 hours ago

  • Toronto Star

3 Canadian national team players among the Whitecaps stricken by illness

Three Canadian national team players were among those who fell ill following the Vancouver Whitecaps' appearance in the CONCACAF Champions Cup final last weekend in Mexico City. The Whitecaps said a 'significant number' of players and staff had a gastrointestinal illness. Three of them — Ali Ahmed, Sam Adekugbe and Jayden Nelson — were ill when they arrived at Canada's training camp in Halifax ahead of Saturday's Canadian Shield match against Ukraine, coach Jesse Marsch said Friday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store